Tibet AIM Pharm. Inc. (SHE:002826)
China
· Delayed Price · Currency is CNY 21.50
-0.74 (-3.33%)
Mar 11, 2026, 9:25 AM CST
Tibet AIM Pharm. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 625.86 | 649.72 | 666.8 | 856.53 | 724.36 | 602.15 | Upgrade
|
| Other Revenue | 2.16 | 2.16 | 0.23 | 0.21 | 1.1 | 0.47 | Upgrade
|
| Revenue | 628.02 | 651.88 | 667.04 | 856.73 | 725.46 | 602.62 | Upgrade
|
| Revenue Growth (YoY) | -2.11% | -2.27% | -22.14% | 18.09% | 20.38% | 8.92% | Upgrade
|
| Cost of Revenue | 123.84 | 205.54 | 325.59 | 480.7 | 464.96 | 386.02 | Upgrade
|
| Gross Profit | 504.19 | 446.34 | 341.45 | 376.03 | 260.5 | 216.6 | Upgrade
|
| Selling, General & Admin | 420.48 | 390.65 | 298.35 | 317.92 | 218.48 | 178.24 | Upgrade
|
| Research & Development | 13.28 | 15.48 | 13.71 | 13.35 | 11.39 | 6.85 | Upgrade
|
| Other Operating Expenses | 6.9 | 12.27 | 11.5 | -8.2 | -9.81 | -7.44 | Upgrade
|
| Operating Expenses | 438.69 | 419.08 | 316.54 | 329.71 | 218.93 | 177.4 | Upgrade
|
| Operating Income | 65.5 | 27.26 | 24.91 | 46.32 | 41.58 | 39.2 | Upgrade
|
| Interest Expense | -0.99 | -0.45 | -1.18 | -0.81 | -0.84 | -1.62 | Upgrade
|
| Interest & Investment Income | 5.79 | 5.2 | 5.06 | 3.93 | 2.92 | 1.55 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0 | 0 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.31 | -0.3 | 1.06 | 3.23 | 2.8 | -1.92 | Upgrade
|
| EBT Excluding Unusual Items | 70.6 | 31.71 | 29.85 | 52.68 | 46.46 | 37.22 | Upgrade
|
| Impairment of Goodwill | - | - | -19.8 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.48 | -0.04 | 0.03 | - | 0.03 | -0.12 | Upgrade
|
| Asset Writedown | -0.21 | -0.2 | -0.13 | -0.08 | -0.08 | -0.05 | Upgrade
|
| Other Unusual Items | 42.05 | 28.91 | 13.65 | 4.1 | 3.6 | 10.29 | Upgrade
|
| Pretax Income | 111.96 | 60.38 | 23.6 | 56.7 | 50.01 | 47.35 | Upgrade
|
| Income Tax Expense | 25.35 | 12.92 | 7.87 | 10.59 | 6.54 | 6.26 | Upgrade
|
| Earnings From Continuing Operations | 86.6 | 47.46 | 15.73 | 46.12 | 43.47 | 41.09 | Upgrade
|
| Minority Interest in Earnings | -0.73 | -1.53 | -0.34 | -1.98 | -1 | - | Upgrade
|
| Net Income | 85.87 | 45.93 | 15.39 | 44.14 | 42.48 | 41.09 | Upgrade
|
| Net Income to Common | 85.87 | 45.93 | 15.39 | 44.14 | 42.48 | 41.09 | Upgrade
|
| Net Income Growth | 157.74% | 198.50% | -65.14% | 3.91% | 3.37% | 10.08% | Upgrade
|
| Shares Outstanding (Basic) | 181 | 184 | 192 | 192 | 193 | 187 | Upgrade
|
| Shares Outstanding (Diluted) | 181 | 184 | 192 | 192 | 193 | 187 | Upgrade
|
| Shares Change (YoY) | -8.40% | -4.48% | 0.23% | -0.61% | 3.37% | 0.07% | Upgrade
|
| EPS (Basic) | 0.48 | 0.25 | 0.08 | 0.23 | 0.22 | 0.22 | Upgrade
|
| EPS (Diluted) | 0.48 | 0.25 | 0.08 | 0.23 | 0.22 | 0.22 | Upgrade
|
| EPS Growth | 181.39% | 212.50% | -65.22% | 4.54% | - | 10.00% | Upgrade
|
| Free Cash Flow | 139.01 | 99.33 | 163.7 | 65.26 | 84.33 | 63.31 | Upgrade
|
| Free Cash Flow Per Share | 0.77 | 0.54 | 0.85 | 0.34 | 0.44 | 0.34 | Upgrade
|
| Dividend Per Share | 0.100 | 0.100 | 0.030 | 0.100 | 0.100 | 0.080 | Upgrade
|
| Dividend Growth | 233.33% | 233.33% | -70.00% | - | 25.00% | 100.00% | Upgrade
|
| Gross Margin | 80.28% | 68.47% | 51.19% | 43.89% | 35.91% | 35.94% | Upgrade
|
| Operating Margin | 10.43% | 4.18% | 3.73% | 5.41% | 5.73% | 6.51% | Upgrade
|
| Profit Margin | 13.67% | 7.05% | 2.31% | 5.15% | 5.85% | 6.82% | Upgrade
|
| Free Cash Flow Margin | 22.13% | 15.24% | 24.54% | 7.62% | 11.62% | 10.51% | Upgrade
|
| EBITDA | 85.12 | 48.82 | 49.05 | 69.02 | 65.24 | 55.95 | Upgrade
|
| EBITDA Margin | 13.55% | 7.49% | 7.35% | 8.06% | 8.99% | 9.28% | Upgrade
|
| D&A For EBITDA | 19.62 | 21.55 | 24.14 | 22.7 | 23.66 | 16.74 | Upgrade
|
| EBIT | 65.5 | 27.26 | 24.91 | 46.32 | 41.58 | 39.2 | Upgrade
|
| EBIT Margin | 10.43% | 4.18% | 3.73% | 5.41% | 5.73% | 6.51% | Upgrade
|
| Effective Tax Rate | 22.65% | 21.39% | 33.37% | 18.67% | 13.08% | 13.21% | Upgrade
|
| Revenue as Reported | 628.02 | 651.88 | 667.04 | 856.73 | 725.46 | 602.62 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.